![Jun Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 17 M $ al 30/06/2026
Jun Liu currently works at Changzhou Qianhong Biopharma Co., Ltd., as Chairman-Supervisory Board from 2024, Zonhon Biopharma Institute, Inc., as Director from 2015, and Aucentra Therapeutics Pty Ltd., as Director.
Mr. Liu also formerly worked at Changzhou Bio-pharma Qianhong Co. Ltd., as Director-Supervisory Board and Jiangsu Biological Technology Association, as Member.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2025 | 18.044.733 ( 5,04 % ) | 17 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CHANGZHOU QIANHONG BIOPHARMA CO.,LTD | Presidente | 19/01/2024 |
Zonhon Biopharma Institute, Inc. | Director/Miembro de la Junta | 09/02/2015 |
Aucentra Therapeutics Pty Ltd.
 Aucentra Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops anti-cancer drugs | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Changzhou Bio-pharma Qianhong Co. Ltd. | Director/Miembro de la Junta | - |
Jiangsu Biological Technology Association | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Changzhou Qianhong Biopharma Co., Ltd.
 Changzhou Qianhong Biopharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures & sells pharmaceutical products | Health Technology |
Jiangsu Biological Technology Association | |
Changzhou Bio-pharma Qianhong Co. Ltd. | |
Zonhon Biopharma Institute, Inc. | |
Aucentra Therapeutics Pty Ltd.
Aucentra Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops anti-cancer drugs | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
